Oversold

HIMS

Same as last week
Valuation50/ 100
Cash flow & growth51/ 100
Upside potential51/ 100
Risk potential60/ 100

HIMS's valuation appears fair, fundamentals are somewhat mixed, while forward estimates point to a return to profit and improving margins, though analyst coverage is limited and estimates vary widely.

Valuation

Valuation stays neutral because earnings are difficult to compare across periods. Business trends, outlook and financial risk still contribute to the overall score.

Cash flow & growth

Business trends are mixed. Over the past year: revenue +28%, operating margin -9.8 percentage points. Free cash flow is 3.5% of revenue. The business score is 50.9/100. Growth, margins and cash generation drive the score. Missing or older data receives less weight.

Favorable scenario

Weaker business results limit upside support. Price history provides the reference because earnings are difficult to compare.

The calculation starts with the stock’s typical weekly price movements, adjusted for business performance and outlook. Unusually large jumps have less influence. The result is 63.4% upside, or about $44.95.

This is a scenario based on our model, not a forecast or probability.

Downside scenario

Historical price swings are the main risk driver, even without a sharp profit decline.

The stock’s historical price swings drive this figure; the separate operating stress is 38.1%. Price history and operating stress provide the reference because comparable earnings do not support a future PE target. Operating stress reflects revenue, earnings, margins, outlook and relevant debt exposure. The larger stress gives 59.9% downside, or about $11.03, with a 15% minimum.

This is a scenario based on our model, not a forecast or probability.

HIMS vs Historical averages

MetricCurrentAverageRelative
PE50x81x39% lower
PE percentile215058% lower
EPS-$0.63-$0.12$0.50 lower
FCF$89.9M$42.3M112% higher
Loading historical comparisons…

HIMS’s fundamentals are mixed relative to their historical averages, while its earnings multiple is lower.

HIMS Forward outlook

MetricOutlook
Forward valuation--
Forward earningsTurning positive
Forward revenueStrong growth
Forward profitabilityStrongly expanding
Analyst coverageLimited
Estimate dispersionWide

HIMS’s outlook is generally improving, supported by an expected return to profitability.

HIMS PE Valuation

Loading pe valuation table…

This table applies HIMS's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.

HIMS Earnings Per Share

Loading earnings per share…

This chart tracks HIMS's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.

HIMS Quarterly Revenue

Loading quarterly revenue…

This chart tracks HIMS's quarterly revenue over time and shows how sales are changing from year to year.

HIMS Free Cash Flow

Loading free cash flow…

This chart tracks HIMS's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.

HIMS Total Shares

Loading shares over time…

This chart tracks changes in HIMS's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.

HIMS Net Leverage

Loading net leverage…

Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.

HIMS PE vs Healthcare Sector

Loading pe vs sector average…

This chart compares HIMS's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.

HIMS Weekly Price

Loading weekly price…

This chart uses HIMS's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.

HIMS Weekly Moving Averages

Loading weekly moving averages…

This chart compares HIMS's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.

HIMS Yearly ROI

Loading yearly ROI…

Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.

INCY

Valuation84/ 100
Cash flow & growth92/ 100
Upside potential62/ 100
Risk potential19/ 100

INCY's valuation is historically cheap, fundamentals are above averages, but weaker than expected earnings are holding it back, though estimates vary widely.

Score change since last week

The score rose 9 points, mainly due to valuation and price changes. Price rose 1.9%, from $124.37 to $126.75.

Valuation and price changes added 9.4 points. The comparison uses the same available inputs on both dates. Displayed changes are rounded to whole points.

Valuation

Historical cheapness: current PE is 15.5× versus the full-history median of 30.2× shown in the valuation table, producing 84.8/100. Positive weekly observations receive equal weight; lower past EPS alone does not disqualify them.

Outlook-adjusted valuation: 84/100. The model applies a 7.2% earnings-growth assumption and a 10% annual return hurdle, with positive credit limited by evidence coverage and confidence.

Forward price scenarios use recent PE history separately. Recent history has a separately weighted median of 19.3× (18-month half-life). The favorable scenario uses 17.9× PE and $9.1 projected EPS, informed by growth, margins and earnings-quality checks. This is a model scenario, not an analyst target. A return to the full-history median is not assumed.

Cash flow & growth

Business trends are strong. Over the past year: revenue +26.9%, earnings +78.4%, operating margin +10.4 percentage points. Free cash flow is 33% of revenue. The business score is 92/100. Growth, margins and cash generation drive the score. Missing or older data receives less weight.

Favorable scenario

Stronger earnings and valuation could support a higher share price.

Our favorable case uses $9.08 of EPS and a 17.9× PE, suggesting a share price of about $162.54. Valuation history and outlook inform the PE.

The displayed favorable scenario is 33.8% upside, or about $162.53.

This is a scenario based on our model, not a forecast or probability.

Downside scenario

Weaker than expected earnings could put pressure on the share price.

Our downside case uses $6.66 of EPS and a 14.8× PE, suggesting a share price of about $98.86 — 19% below today’s price. Valuation history and outlook inform the PE.

This is a scenario based on our model, not a forecast or probability.

INCY vs Historical averages

MetricCurrentAverageRelative
PE15x67x77% lower
PE percentile7.75085% lower
EPS$7.85$2.37231% higher
FCF$1.9B$595.9M222% higher
Loading historical comparisons…

INCY’s earnings and cash flow are above their historical averages, while its earnings multiple is lower.

INCY Forward outlook

MetricOutlook
Forward valuationStrongly deteriorating
Forward earningsStrong decline
Forward revenueStable
Forward profitabilityStrongly contracting
Analyst coverageModerate
Estimate dispersionWide

INCY’s outlook is weakening, with weaker expected earnings weighing on the picture.

INCY PE Valuation

Loading pe valuation table…

This table applies INCY's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.

INCY Earnings Per Share

Loading earnings per share…

This chart tracks INCY's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.

INCY Quarterly Revenue

Loading quarterly revenue…

This chart tracks INCY's quarterly revenue over time and shows how sales are changing from year to year.

INCY Free Cash Flow

Loading free cash flow…

This chart tracks INCY's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.

INCY Total Shares

Loading shares over time…

This chart tracks changes in INCY's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.

INCY Net Leverage

Loading net leverage…

Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.

INCY PE vs Healthcare Sector

Loading pe vs sector average…

This chart compares INCY's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.

INCY Weekly Price

Loading weekly price…

This chart uses INCY's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.

INCY Weekly Moving Averages

Loading weekly moving averages…

This chart compares INCY's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.

INCY Yearly ROI

Loading yearly ROI…

Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.